Pancreas Carcinoma Clinical Trials in Hangzhou, Zhejiang
2 recruitingHangzhou, Zhejiang, China
Showing 1–2 of 2 trials
Recruiting
Phase 3
Firstline Sequential AG and mFOLFOX Combined With Serplulimab and Bevacizumab Versus AG Chemotherapy Alone in Advanced Pancreatic Cancer
Non-Resectable Pancreas Carcinoma
Zhejiang Cancer Hospital292 enrolled1 locationNCT07235930
Recruiting
Phase 2
Sequential AG and mFOLFOX Combined With Serplulimab Injection and Bevacizumab Injection in Untreated Advanced Pancreatic Cancer
Non-Resectable Pancreas Carcinoma
Zhejiang Cancer Hospital37 enrolled1 locationNCT06393166